Nav: Home

High prevalence of diabetes, prediabetes in China

June 27, 2017

A large, nationally representative survey in 2013 of adults in China finds that the estimated overall prevalence of diabetes was about 11 percent and that of prediabetes was nearly 36 percent, according to a study published by JAMA.

Previous studies have shown increasing prevalence of diabetes in China, which now has the world's largest diabetes epidemic. To provide more recent estimates of the prevalence of diabetes and prediabetes, Linhong Wang, Ph.D., of the Chinese Center for Disease Control and Prevention, Beijing, and Yonghua Hu, M.D., of Peking University, Beijing, and colleagues analyzed data from a nationally representative survey conducted in 2013 in mainland China, which included 170,287 participants. Fasting plasma glucose and hemoglobin A1c levels were measured for all participants. Diabetes and prediabetes were defined according to the 2010 American Diabetes Association criteria.

Among the findings:
  • The estimated prevalence of total diagnosed and undiagnosed diabetes was 10.9 percent; that of diagnosed diabetes, 4 percent; and that of prediabetes, 35.7 percent.

  • Among persons with diabetes, 36.5 percent were aware of their diagnosis and 32.2 percent were treated; 49.2 percent of patients treated had adequate glycemic control.

  • Tibetan and Muslim Chinese had significantly lower prevalence of diabetes than Han participants (14.7 percent for Han, 4.3 percent for Tibetan, and 10.6 percent for Muslim).


The authors write that the prevalence of diabetes of 10.9 percent was only slightly lower than the prevalence of total diabetes in the U.S. population (12-14 percent) in 2011-2012. The estimated prevalence of prediabetes in China (35.7 percent) was similar to the U.S. (36.5 percent in 2011-2012). Overall, 47 percent of the Chinese adult population was estimated to have either diabetes or prediabetes, slightly lower than the 49 percent to 52 percent estimate in the U.S. population.

With approximately 1.09 billion adults in total in mainland China, it is projected that 388.1 million Chinese adults (200.4 million men and 187.7 million women) may have had prediabetes in 2013.

The authors note that differences from previous higher prevalence estimates for 2010 may be due to an alternate method of measuring hemoglobin A1c.

A limitation of the study was that the researchers did not distinguish between type 1 and 2 diabetes.
-end-
For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jama.2017.7596)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...